📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Towards a stratified targeted approach with biologic treatments in rheumatoid arthritis: role of synovial pathobiology. (2015)

First Author: Astorri E

Attributed to: MICA: Interleukin-21 in rheumatoid arthritis: exploring its therapeutic potential for the development of a novel targeted biologic therapy. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2174/1381612821666150310145758

PubMed Identifier: 25760296

Publication URI: http://europepmc.org/abstract/MED/25760296

Type: Journal Article/Review

Volume: 21

Parent Publication: Current pharmaceutical design

Issue: 17

ISSN: 1381-6128